BioTech
The NIH’s drastic cut to indirect cost rates is a critical threat to U.S. research infrastructure
The National Institutes of Health has made a landmark decision that could irreparably damage the backbone of American scientific innovation: a dramatic reduction in the
Harlan M. Krumholz
February 8, 2025